Search Results - "Bakker, A.L.M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Value of echocardiography using knowledge-based reconstruction in determining right ventricular volumes in pulmonary sarcoidosis: comparison with cardiac magnetic resonance imaging by Mathijssen, H, Huitema, M.P, Bakker, A.L.M, Akdim, F, Van Es, H.W, Grutters, J.C, Post, M.C

    Published in European heart journal (12-10-2021)
    “…Abstract Background Right ventricular (RV) dysfunction in sarcoidosis is associated with adverse outcomes. Assessment of RV function by conventional…”
    Get full text
    Journal Article
  2. 2

    Mortality in a well-defined group of predominantly Caucasian pulmonary sarcoidosis patients by Huitema, M.P, Mathijssen, H, Bakker, A.L.M, Mager, J.J, Grutters, J.C, Post, M.C

    Published in European heart journal (01-11-2020)
    “…Abstract Background Sarcoidosis is an inflammatory systemic disease. Mortality has often been described in patients with more advanced disease, especially in…”
    Get full text
    Journal Article
  3. 3

    Aetiology of sarcoidosis-associated pulmonary hypertension by Mathijssen, H, Huitema, M.P, Bakker, A.L.M, Smits, F, Snijder, R.J, Mager, H.J, Grutters, J.C, Post, M.C

    Published in European heart journal (01-11-2020)
    “…Abstract Background Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and its aetiology is unclear. The severity of PH may not…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Effectiveness and safety of infliximab in cardiac Sarcoidosis by Bakker, A.L.M., Mathijssen, H., Azzahhafi, J., Swaans, M.J., Veltkamp, M., Keijsers, R.G.M., Akdim, F., Post, M.C., Grutters, J.C.

    Published in International journal of cardiology (01-05-2021)
    “…Immunosuppressive therapy in active cardiac sarcoidosis (CS) might prevent potential life-threatening complications. Infliximab (IFX) is a tumor necrosis…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening by Huitema, M.P., Mathijssen, H., Bakker, A.L.M., Mager, J.J., van Houten, L., Grutters, J.C., Post, M.C.

    Published in Respiratory medicine (01-04-2022)
    “…Sarcoidosis is a systemic disease of unknown aetiology with significant morbidity and mortality. The PULSAR study prospectively performed cardiac analysis…”
    Get full text
    Journal Article
  8. 8

    Safety of macitentan in sarcoidosis-associated pulmonary hypertension: a case-series by Mathijssen, H, Huitema, M P, Bakker, A L M, Mager, J J, Snijder, R J, Grutters, J C, Post, M C

    “…Pulmonary hypertension (PH) is a known complication of pulmonary sarcoidosis and is associated with higher morbidity and mortality. Currently, there are no…”
    Get full text
    Journal Article
  9. 9

    Complications during percutaneous edge-to-edge mitral valve repair by Bakker, A.L.M., Swaans, M.J., van der Heyden, J.A.S., Eefting, F.D., Rensing, B.J.W.M., Post, M.C.

    Published in Herz (01-08-2013)
    “…Transcatheter edge-to-edge mitral valve repair is an approach for treating mitral regurgitation, which is an alternative for surgery in patients with a high…”
    Get full text
    Journal Article